Biologics Growth Faster Than Implants (Biloine Young @ OTW)
The rush to engage in stem cell research is leading to double-digit annual sales growth in the orthopedic biomaterials market, according to the health care market research firm Kalorama Information. A factor driving revenue growth for biomaterials is that insurance companies are more likely to approve reimbursement for biomaterials than for standard materials, indicated Bruce Carlson, publisher of Kalorama Information. “Their efficacy in reducing healing time and increasing the chance that an implant surgery will be successful ...
